HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ondrej Hes Selected Research

Vimentin

2/2022Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases.
1/2022Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
8/2018Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
8/2018Solid pseudopapillary neoplasm (SPN) of the testis: Comprehensive mutational analysis of 6 testicular and 8 pancreatic SPNs.
12/2016Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.
10/2016Pancreatic analogue solid pseudopapillary neoplasm arising in the paratesticular location. The first case report.
7/2016"Mucin"-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases.
7/2015Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
12/2014Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
4/2014Distinctive renal cell tumor simulating atrophic kidney with 2 types of microcalcifications. Report of 3 cases.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ondrej Hes Research Topics

Disease

89Neoplasms (Cancer)
02/2022 - 01/2002
30Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 12/2007
9Carcinoma (Carcinomatosis)
01/2020 - 07/2006
7Kidney Neoplasms (Kidney Cancer)
01/2022 - 12/2007
6Neoplasm Metastasis (Metastasis)
01/2021 - 02/2008
5Fibrosis (Cirrhosis)
11/2019 - 12/2007
5Hemorrhage
01/2015 - 02/2006
4Necrosis
05/2022 - 06/2006
4Prostatic Neoplasms (Prostate Cancer)
12/2020 - 04/2013
4Adenocarcinoma
09/2020 - 01/2005
4Atrophy
11/2019 - 02/2009
4Viremia
01/2019 - 02/2009
3Testicular Neoplasms (Testicular Cancer)
01/2021 - 05/2006
3Leiomyomatosis
01/2021 - 01/2016
3Adenoma (Adenomas)
11/2019 - 12/2013
3Hyperplasia
11/2019 - 10/2005
2Cysts
10/2021 - 12/2018
2Perivascular Epithelioid Cell Neoplasms
01/2018 - 01/2016
2Angiomyolipoma
01/2018 - 03/2015
2Oxyphilic Adenoma (Oncocytoma)
01/2017 - 12/2007
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
11/2014 - 03/2013
2Seminoma
04/2014 - 05/2006
2Hypertension (High Blood Pressure)
01/2013 - 08/2011
2Chronic Kidney Failure (Chronic Renal Failure)
11/2012 - 12/2010
2renal Oncocytoma
06/2011 - 12/2007
1Inflammation (Inflammations)
05/2022
1Granuloma
05/2022
1Sarcoidosis (Schaumann Disease)
05/2022
1Urogenital Neoplasms
05/2021
1Microsatellite Instability
01/2021
1Villous Adenoma
09/2020
1Metaplasia
09/2020
1Basal Cell Carcinoma (Rodent Ulcer)
11/2019

Drug/Important Bio-Agent (IBA)

17VimentinIBA
02/2022 - 01/2004
9Capsules (Microcapsules)IBA
01/2022 - 10/2005
9Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2005
8Biological ProductsIBA
11/2019 - 02/2008
7Keratin-7 (Cytokeratin 7)IBA
03/2019 - 12/2008
7AntigensIBA
01/2019 - 02/2008
6trans-sodium crocetinate (crocetin)IBA
02/2022 - 01/2016
6Cathepsin KIBA
02/2020 - 01/2013
6ParaffinIBA
11/2019 - 06/2006
6Formaldehyde (Formol)FDA Link
11/2019 - 06/2006
6Mucin-1 (CA 15-3 Antigen)IBA
12/2016 - 02/2008
6ParvalbuminsIBA
12/2016 - 02/2008
6S100 Proteins (S 100 Protein)IBA
10/2016 - 07/2005
5Calbindin 2IBA
02/2022 - 07/2005
5Inhibins (Inhibin)IBA
02/2022 - 07/2005
5MART-1 AntigenIBA
02/2022 - 04/2010
5Messenger RNA (mRNA)IBA
01/2021 - 02/2013
5Fumarate Hydratase (Fumarase)IBA
01/2021 - 01/2016
5SynaptophysinIBA
07/2019 - 01/2010
5ValganciclovirFDA Link
01/2019 - 01/2010
5Cadherins (E-Cadherin)IBA
10/2016 - 12/2008
4Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 10/2013
4Chromogranin AIBA
07/2019 - 01/2010
4MucinsIBA
02/2019 - 09/2012
4Valacyclovir (Valtrex)FDA LinkGeneric
01/2019 - 01/2010
4Biomarkers (Surrogate Marker)IBA
01/2018 - 12/2007
4Keratins (Keratin)IBA
01/2017 - 09/2012
3RNA (Ribonucleic Acid)IBA
10/2021 - 08/2007
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 04/2014
3CateninsIBA
01/2019 - 10/2016
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 11/2003
3AntibodiesIBA
11/2013 - 07/2005
3OxalatesIBA
01/2011 - 11/2008
2Colloids (Colloid)IBA
10/2021 - 09/2020
2ThyroglobulinFDA Link
10/2021 - 04/2014
2Cyclin D1IBA
10/2021 - 10/2016
2Transcription Factors (Transcription Factor)IBA
05/2021 - 03/2011
2LigandsIBA
01/2021 - 08/2017
2Untranslated RNA (Noncoding RNA)IBA
01/2018 - 01/2014
2MicroRNAs (MicroRNA)IBA
01/2018 - 01/2014
2Phosphopyruvate Hydratase (Enolase)IBA
10/2016 - 08/2015
2Prostate-Specific Antigen (Semenogelase)IBA
01/2016 - 07/2005
2Carbonic Anhydrase IXIBA
05/2015 - 04/2014
2DesminIBA
03/2015 - 01/2004
2Keratin-20 (Cytokeratin 20)IBA
04/2014 - 07/2010
2CollagenIBA
01/2014 - 10/2005
2Immunoglobulin A (IgA)IBA
11/2013 - 12/2007
2Racemases and Epimerases (Epimerases and Racemases)IBA
07/2013 - 04/2010
2ReninIBA
01/2013 - 08/2011
2Antiviral Agents (Antivirals)IBA
09/2012 - 02/2009
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2010 - 04/2010
2placental alkaline phosphataseIBA
07/2010 - 04/2010
1Mechanistic Target of Rapamycin Complex 1IBA
01/2022
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2022
1Anaplastic Lymphoma KinaseIBA
01/2021
1raf KinasesIBA
12/2020
1IronIBA
02/2020

Therapy/Procedure

12Therapeutics
02/2022 - 02/2009
8Nephrectomy
05/2022 - 01/2002
4Prostatectomy (Retropubic Prostatectomy)
01/2020 - 01/2005
4Renal Dialysis (Hemodialysis)
11/2012 - 11/2008
3Drug Therapy (Chemotherapy)
05/2022 - 03/2015
3Immunotherapy
05/2022 - 01/2017
3Kidney Transplantation
11/2019 - 06/2006
2Lymph Node Excision (Lymph Node Dissection)
05/2019 - 01/2005
2Lasers (Laser)
05/2009 - 01/2008
1Contraindications
01/2020